Jane Birtwistle

690 total citations
21 papers, 554 citations indexed

About

Jane Birtwistle is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Jane Birtwistle has authored 21 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hematology and 5 papers in Immunology. Recurrent topics in Jane Birtwistle's work include Multiple Myeloma Research and Treatments (7 papers), Immune Cell Function and Interaction (4 papers) and HIV/AIDS drug development and treatment (4 papers). Jane Birtwistle is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Immune Cell Function and Interaction (4 papers) and HIV/AIDS drug development and treatment (4 papers). Jane Birtwistle collaborates with scholars based in United Kingdom, Germany and United States. Jane Birtwistle's co-authors include Christopher M. Bunce, Mark T. Drayson, Nicholas Davies, Farhat L. Khanim, Rachel E. Hayden, J.P. Ride, Ye Htun Oo, David Adams, Hannah C. Jeffery and Richard M. Green and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jane Birtwistle

19 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Birtwistle United Kingdom	12	209	127	117	102	101	21	554
Paul Guéguen France	14	167 0.8×	97 0.8×	62 0.5×	136 1.3×	75 0.7×	48	669
Yifeng Tao China	14	190 0.9×	36 0.3×	94 0.8×	92 0.9×	37 0.4×	37	512
Yuh‐Ching Twu Taiwan	18	263 1.3×	175 1.4×	39 0.3×	98 1.0×	22 0.2×	36	737
Nicholas Davies United Kingdom	15	584 2.8×	86 0.7×	33 0.3×	104 1.0×	191 1.9×	25	1000
Hironobu Fujii Japan	14	284 1.4×	245 1.9×	47 0.4×	142 1.4×	34 0.3×	21	554
Philippe Rostagno France	15	354 1.7×	68 0.5×	153 1.3×	74 0.7×	51 0.5×	23	777
Heike Liewen Germany	13	328 1.6×	103 0.8×	44 0.4×	98 1.0×	111 1.1×	17	644
Toshiya Kawaguchi Japan	7	399 1.9×	47 0.4×	360 3.1×	42 0.4×	47 0.5×	8	726
Ewa Gruszewska Poland	13	167 0.8×	94 0.7×	141 1.2×	199 2.0×	47 0.5×	50	505

Countries citing papers authored by Jane Birtwistle

Since Specialization

Citations

This map shows the geographic impact of Jane Birtwistle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Birtwistle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Birtwistle more than expected).

Fields of papers citing papers by Jane Birtwistle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Birtwistle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Birtwistle. The network helps show where Jane Birtwistle may publish in the future.

Co-authorship network of co-authors of Jane Birtwistle

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Birtwistle. A scholar is included among the top collaborators of Jane Birtwistle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Birtwistle. Jane Birtwistle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faustini, Sian, James Hodson, Jane Birtwistle, et al.. (2024). Comparison of short- and long-term humoral immune responses to pneumococcal polysaccharide and glycoconjugate vaccines in an HIV-infected population. Journal of Infection. 89(5). 106282–106282. 1 indexed citations

Berlanga, Oscar, Jane Birtwistle, Sariah J. Allen, Gill Malin, & Gabriella Lakos. (2023). B-371 Two Cases of Multiple Myeloma Achieving Complete Remission But Presenting Residual M-protein by the EXENT® Solution. Clinical Chemistry. 69(Supplement_1). 2 indexed citations

Allen, Sariah J., Jane Birtwistle, Oscar Berlanga, Gill Malin, & Gabriella Lakos. (2023). B-180 The EXENT® Solution Provides Evidence for High Prevalence of Multiple M-proteins in Monoclonal Gammopathies. Clinical Chemistry. 69(Supplement_1). 1 indexed citations

Berlanga, Oscar, Jane Birtwistle, Habib El‐Khoury, et al.. (2023). Multi-Center Clinical Validation of a Mass Spectrometry Immunoassay for the Diagnosis and Monitoring of Multiple Myeloma and Associated Disorders. Blood. 142(Supplement 1). 3667–3667. 1 indexed citations

Berlanga, Oscar, et al.. (2023). PB2139: MONITORING OLIGOSECRETORY MULTIPLE MYELOMA USING MALDI-TOF MASS SPECTROMETRY. HemaSphere. 7(S3). e46491ff–e46491ff.

Lutz, Philipp, Hannah C. Jeffery, Nicholas Jones, et al.. (2019). NK Cells in Ascites From Liver Disease Patients Display a Particular Phenotype and Take Part in Antibacterial Immune Response. Frontiers in Immunology. 10. 1838–1838. 8 indexed citations

Jeffery, Hannah C., Stuart Hunter, E Humphreys, et al.. (2019). Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases. The Journal of Immunology. 203(5). 1151–1159. 30 indexed citations

Drayson, Mark T., Jennifer Heaney, John P. Campbell, et al.. (2017). Diagnosis and Monitoring for Light Chain Only and Oligosecretory Myeloma Using Serum Free Light Chain Tests. Clinical Lymphoma Myeloma & Leukemia. 17(1). e96–e96.

Jeffery, Hannah C., et al.. (2017). Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 12(12). e0188649–e0188649. 41 indexed citations

10.

Heaney, Jennifer, John P. Campbell, Jane Birtwistle, et al.. (2017). Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests. British Journal of Haematology. 178(2). 220–230. 25 indexed citations

11.

MacLennan, Calman A., Jane Birtwistle, Sian Faustini, et al.. (2016). Comparison of immune response after vaccination with polysaccharide and glycoconjugate vaccines against encapsulated bacteria between HIV-infected and HIV-non-infected adults in the UK. HIV Medicine. 17. 26–27. 1 indexed citations

12.

MacLennan, Calman A., Alex Richter, James Hodson, et al.. (2016). Brief Report: Immunization of HIV-Infected Adults in the UK With Haemophilus influenzae b/Meningococcal C Glycoconjugate and Pneumococcal Polysaccharide Vaccines. JAIDS Journal of Acquired Immune Deficiency Syndromes. 73(3). 287–293. 6 indexed citations

13.

Chen, Yung‐Yi, Hannah C. Jeffery, Stuart Hunter, et al.. (2016). Human intrahepatic regulatory T cells are functional, require IL‐2 from effector cells for survival, and are susceptible to Fas ligand‐mediated apoptosis. Hepatology. 64(1). 138–150. 71 indexed citations

14.

Campbell, John P., Mark Cobbold, Yanyun Wang, et al.. (2013). Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Journal of Immunological Methods. 391(1-2). 1–13. 36 indexed citations

15.

Birtwistle, Jane, Alex Richter, John P. Campbell, et al.. (2012). Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay. Journal of Immunological Methods. 377(1-2). 37–46. 23 indexed citations

16.

Khanim, Farhat L., Blair Merrick, Monika Jankute, et al.. (2011). Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production. Blood Cancer Journal. 1(10). e39–e39. 64 indexed citations

17.

Birtwistle, Jane, Rachel E. Hayden, Farhat L. Khanim, et al.. (2009). The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 662(1-2). 67–74. 68 indexed citations

18.

Khanim, Farhat L., Rachel E. Hayden, Jane Birtwistle, et al.. (2009). Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia. PLoS ONE. 4(12). e8147–e8147. 63 indexed citations

19.

Davies, Nicholas, Rachel E. Hayden, Paul J. Simpson, et al.. (2009). AKR1C Isoforms Represent a Novel Cellular Target for Jasmonates alongside Their Mitochondrial-Mediated Effects. Cancer Research. 69(11). 4769–4775. 53 indexed citations

20.

Hayden, Richard E., Guy Pratt, Nicholas Davies, et al.. (2008). Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ12,14,PGJ2. Leukemia. 23(2). 292–304. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact